Development of a μO-Conotoxin Analogue with Improved Lipid Membrane Interactions and Potency for the Analgesic Sodium Channel NaV1.8
Jennifer R. Deuis(The University of Queensland), Irina Vetter(Centre National de la Recherche Scientifique), Marco Inserra(The University of Queensland), Richard J. Lewis(AstraZeneca (Netherlands)), Mehdi Mobli(The University of Queensland), Sónia Troeira Henriques(Translational Research Institute), Zoltan Dekan(The University of Queensland), Paul F. Alewood(The University of Queensland), Christina I. Schroeder(Research Institute for Bioscience and Biotechnology), Marie‐Isabel Aguilar(University of Zurich), David J. Craik(The University of Queensland), Tzong-Hsien Lee(Monash University)
Cited by 40
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422